| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
Indirubin-5-sulfonate manufacturers
|
| | Indirubin-5-sulfonate Basic information |
| Product Name: | Indirubin-5-sulfonate | | Synonyms: | INDIRUBIN-5-SULFONATE;Indirubin 5 sulfonate,Indirubin5sulfonate;1H-Indole-5-sulfonic acid, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-2,3-dihydro-2-oxo- | | CAS: | 244021-67-8 | | MF: | C16H10N2O5S | | MW: | 342.33 | | EINECS: | | | Product Categories: | | | Mol File: | 244021-67-8.mol |  |
| | Indirubin-5-sulfonate Chemical Properties |
| density | 1.647±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | -1.02±0.20(Predicted) |
| | Indirubin-5-sulfonate Usage And Synthesis |
| Uses | Indirubin-5-sulfonate is a cyclin-dependent kinase (CDK) inhibitor, with IC50 values of 55 nM, 35 nM, 150 nM, 300 nM and 65 nM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK4/cyclin D1, and CDK5/p35, respectively[1]. Indirubin-5-sulfonate also shows inhibitory activity against GSK-3β[2]. | | IC 50 | Cdk1/cyclin B: 55 nM (IC50); cdk2/cyclin A: 35 nM (IC50); CDK2/cyclinE: 150 nM (IC50); Cdk4/cyclin D1: 300 nM (IC50); CDK5/p35: 65 nM (IC50); GSK-3β | | References | [1] Hoessel R, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol. 1999 May;1(1):60-7. DOI:10.1038/9035
[2] Leclerc S, et al. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors J Biol Chem. 2001 Jan 5;276(1):251-60. DOI:10.1074/jbc.M002466200 |
| | Indirubin-5-sulfonate Preparation Products And Raw materials |
|